عنوان
پدید آورنده
موضوع
رده
کتابخانه
محل استقرار
LA2zf9r6vw
انگلیسی
Ponatinib-induced ichthyosiform drug eruption: insights into acquired ichthyosis
[Article]
Xu, Haoming; Busam, Klaus J; Mauro, Michael J; Markova, Alina
Cutaneous adverse events are commonly experienced with use of tyrosine kinase inhibitors in the treatment of leukemia and typically include nonspecific cutaneous eruptions and xerosis. We report the case of a man who experienced an ichthyosiform drug eruption while taking ponatinib, a third-generation tyrosine kinase inhibitor. Disruption of epidermal growth pathways through inhibition of various receptor tyrosine kinases by ponatinib may offer insights into the pathophysiologic mechanisms behind acquired ichthyosis.
2017
Dermatology Online Journal
23/10
Xu, Haoming; Busam, Klaus J; Mauro, Michael J; Markova, Alina
مطالعه متن کتاب [Article]
275578
a
Y
